DiaMedica Therapeutics Inc
(NAS:DMAC)
$
2.39
-0.01 (-0.42%)
Market Cap: 90.73 Mil
Enterprise Value: 44.98 Mil
PE Ratio: 0
PB Ratio: 1.96
GF Score: 36/100 DiaMedica Therapeutics Inc (DMAC) Transcripts
- Q4 2023 DiaMedica Therapeutics Inc Earnings Call TranscriptMar 20, 2024$2.77 (-1.77%)Earnings
- Q3 2023 DiaMedica Therapeutics Inc Earnings Call TranscriptNov 14, 2023$2.5 (+6.84%)Earnings
- Q2 2023 DiaMedica Therapeutics Inc Earnings Call TranscriptAug 15, 2023$2.97 (+4.40%)Earnings
- Q1 2023 DiaMedica Therapeutics Inc Earnings Call TranscriptMay 16, 2023$1.77 (-10.77%)Earnings
- Q4 2022 DiaMedica Therapeutics Inc Earnings Call TranscriptMar 29, 2023$1.47 (-3.29%)Earnings
- DiaMedica Therapeutics Inc To Discuss its ReMEDy2 Update TranscriptOct 27, 2022
- Q2 2022 DiaMedica Therapeutics Inc Earnings Call TranscriptAug 11, 2022$1.9 (+9.83%)Earnings
- Q1 2022 DiaMedica Therapeutics Inc Earnings Call TranscriptMay 05, 2022$2.55 (+2.82%)Earnings
- Q4 2021 DiaMedica Therapeutics Inc Earnings Call TranscriptMar 15, 2022$2.3 (-0.43%)Earnings
- Q3 2021 DiaMedica Therapeutics Inc Earnings Call TranscriptNov 11, 2021$4.53 (+1.57%)Earnings
- Q2 2021 DiaMedica Therapeutics Inc Earnings Call TranscriptAug 12, 2021$3.21 (-5.03%)Earnings
- DiaMedica Therapeutics Inc REDUX Phase 2 CKD Interim Results Call TranscriptJun 29, 2021
- Q1 2021 DiaMedica Therapeutics Inc Earnings Call TranscriptMay 06, 2021$8.57 (-9.22%)Earnings
- Q4 2020 DiaMedica Therapeutics Inc Earnings Call TranscriptMar 11, 2021$9.12 (+3.52%)Earnings
- Q3 2020 DiaMedica Therapeutics Inc Earnings Call TranscriptNov 05, 2020$4.31 (-5.90%)Earnings
- Q2 2020 DiaMedica Therapeutics Inc Earnings Call TranscriptAug 12, 2020$5.3 (-1.85%)Earnings
- Q1 2020 DiaMedica Therapeutics Inc Earnings Call TranscriptMay 14, 2020$4.5 (+17.19%)Earnings
- Q4 2019 DiaMedica Therapeutics Inc Earnings Call TranscriptMar 24, 2020$2.25 (-2.60%)Earnings
- Q2 2019 DiaMedica Therapeutics Inc Earnings Call TranscriptAug 14, 2019$2.26 (-34.68%)Earnings
- 1